
    
      The main objective of this study is to evaluate the safety, effectiveness and tolerability of
      three concentrations of A-101 25%, 32.5%, and 40%, when applied to individual seborrheic
      keratosis target lesions on the back compared with a matching A-101 vehicle.
    
  